1. Home
  2. STVN vs CMA Comparison

STVN vs CMA Comparison

Compare STVN & CMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • STVN
  • CMA
  • Stock Information
  • Founded
  • STVN 1949
  • CMA 1849
  • Country
  • STVN Italy
  • CMA United States
  • Employees
  • STVN N/A
  • CMA N/A
  • Industry
  • STVN Containers/Packaging
  • CMA Major Banks
  • Sector
  • STVN Consumer Discretionary
  • CMA Finance
  • Exchange
  • STVN Nasdaq
  • CMA Nasdaq
  • Market Cap
  • STVN 6.6B
  • CMA 7.7B
  • IPO Year
  • STVN 2021
  • CMA N/A
  • Fundamental
  • Price
  • STVN $24.59
  • CMA $63.78
  • Analyst Decision
  • STVN Buy
  • CMA Hold
  • Analyst Count
  • STVN 6
  • CMA 21
  • Target Price
  • STVN $25.08
  • CMA $61.52
  • AVG Volume (30 Days)
  • STVN 337.6K
  • CMA 1.4M
  • Earning Date
  • STVN 08-05-2025
  • CMA 07-18-2025
  • Dividend Yield
  • STVN 0.26%
  • CMA 4.45%
  • EPS Growth
  • STVN N/A
  • CMA 4.95
  • EPS
  • STVN 0.50
  • CMA 5.29
  • Revenue
  • STVN $1,215,562,040.00
  • CMA $3,234,000,000.00
  • Revenue This Year
  • STVN $8.69
  • CMA $7.20
  • Revenue Next Year
  • STVN $10.67
  • CMA $3.01
  • P/E Ratio
  • STVN $49.56
  • CMA $12.06
  • Revenue Growth
  • STVN 3.81
  • CMA N/A
  • 52 Week Low
  • STVN $17.12
  • CMA $48.12
  • 52 Week High
  • STVN $25.88
  • CMA $73.45
  • Technical
  • Relative Strength Index (RSI)
  • STVN 56.81
  • CMA 74.42
  • Support Level
  • STVN $24.06
  • CMA $57.53
  • Resistance Level
  • STVN $25.36
  • CMA $58.73
  • Average True Range (ATR)
  • STVN 1.10
  • CMA 1.25
  • MACD
  • STVN 0.01
  • CMA 0.65
  • Stochastic Oscillator
  • STVN 67.06
  • CMA 98.69

About STVN Stevanato Group S.p.A.

Stevanato Group SpA is a provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries. It delivers an integrated, end-to-end portfolio of products, processes, and services that address customer needs across the entire drug life cycle including development, clinical, and commercial stages. It has two segments; Biopharmaceutical and Diagnostic Solutions which generates key revenue, includes all the products, processes and services developed and provided for the containment and delivery of pharmaceutical and biotechnology drugs and reagents, as well as the production of diagnostic consumables and its other segment is Engineering. Geographically, the company derives majority revenue from Europe, Middle East and Africa.

About CMA Comerica Incorporated

With assets of around $80 billion, Comerica is primarily a relationship-based commercial bank headquartered in Dallas. In addition to Texas, Comerica's other primary geographies are California and Michigan, with locations also in Arizona and Florida and select businesses operating in several other states as well as Canada and Mexico.

Share on Social Networks: